Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.4B |
| FY2017, ended Dec 31, 2017 | $27.1B |
| FY2018, ended Dec 31, 2018 | $28.2B |
| FY2019, ended Dec 31, 2019 | $30.3B |
| FY2020, ended Dec 31, 2020 | $32.6B |
| FY2021, ended Dec 31, 2021 | $40.1B |
| FY2022, ended Dec 31, 2022 | $35.9B |
| FY2023, ended Dec 31, 2023 | $36.8B |
| FY2024, ended Dec 31, 2024 | $37.4B |
| FY2025, ended Dec 31, 2025 | $41.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $43.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.36B |
| FY2017, ended Dec 31, 2017 | $5.88B |
| FY2018, ended Dec 31, 2018 | $5.69B |
| FY2019, ended Dec 31, 2019 | $5.60B |
| FY2020, ended Dec 31, 2020 | $5.65B |
| FY2021, ended Dec 31, 2021 | $6.58B |
| FY2022, ended Dec 31, 2022 | $6.84B |
| FY2023, ended Dec 31, 2023 | $7.08B |
| FY2024, ended Dec 31, 2024 | $7.55B |
| FY2025, ended Dec 31, 2025 | $8.21B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $8.72B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.64B | — |
| FY2017, ended Dec 31, 2017 | $1.34B | $712M |
| FY2018, ended Dec 31, 2018 | $1.54B | $942M |
| FY2019, ended Dec 31, 2019 | $1.29B | $1.12B |
| FY2020, ended Dec 31, 2020 | $904M | $1.15B |
| FY2021, ended Dec 31, 2021 | $1.57B | $1.48B |
| FY2022, ended Dec 31, 2022 | $1.32B | $1.15B |
| FY2023, ended Dec 31, 2023 | $1.60B | $1.32B |
| FY2024, ended Dec 31, 2024 | $1.49B | $1.43B |
| FY2025, ended Dec 31, 2025 | $1.56B | $1.64B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.22B | $1.68B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $725M |
| FY2017, ended Dec 31, 2017 | $1.52B |
| FY2018, ended Dec 31, 2018 | $292M |
| FY2019, ended Dec 31, 2019 | $605M |
| FY2020, ended Dec 31, 2020 | $730M |
| FY2021, ended Dec 31, 2021 | $486M |
| FY2022, ended Dec 31, 2022 | $367M |
| FY2023, ended Dec 31, 2023 | $512M |
| FY2024, ended Dec 31, 2024 | $616M |
| FY2025, ended Dec 31, 2025 | $709M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $674M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.19B |
| FY2017, ended Dec 31, 2017 | $10.2B |
| FY2018, ended Dec 31, 2018 | $10.4B |
| FY2019, ended Dec 31, 2019 | $11.0B |
| FY2020, ended Dec 31, 2020 | $10.7B |
| FY2021, ended Dec 31, 2021 | $11.2B |
| FY2022, ended Dec 31, 2022 | $12.3B |
| FY2023, ended Dec 31, 2023 | $11.3B |
| FY2024, ended Dec 31, 2024 | $11.4B |
| FY2025, ended Dec 31, 2025 | $12.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $15.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 22.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 354M |
| FY2017, ended Dec 31, 2017 | 333M |
| FY2018, ended Dec 31, 2018 | 306M |
| FY2019, ended Dec 31, 2019 | 301M |
| FY2020, ended Dec 31, 2020 | 300M |
| FY2021, ended Dec 31, 2021 | 289M |
| FY2022, ended Dec 31, 2022 | 280M |
| FY2023, ended Dec 31, 2023 | 281M |
| FY2024, ended Dec 31, 2024 | 279M |
| FY2025, ended Dec 31, 2025 | 276M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 273M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | — | — |
| FY2017, ended Dec 31, 2017 | $1.96B | $65.0M |
| FY2018, ended Dec 31, 2018 | $2.39B | $50.0M |
| FY2019, ended Dec 31, 2019 | $815M | $59.0M |
| FY2020, ended Dec 31, 2020 | $239M | $97.0M |
| FY2021, ended Dec 31, 2021 | $1.59B | $75.0M |
| FY2022, ended Dec 31, 2022 | $1.20B | $84.0M |
| FY2023, ended Dec 31, 2023 | $50.0M | $95.0M |
| FY2024, ended Dec 31, 2024 | $441M | $69.0M |
| FY2025, ended Dec 31, 2025 | $552M | $70.0M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $888M | $68.0M |
Valuation
At current price- Market Cap
- $40.8B
- P/E
- 18.4×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.7×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 18.8×
Growth
Trailing 12 months- Revenue (TTM)
- $8.72B
- Revenue Growth YoY
- 10.3%
- Revenue CAGR 3Y
- 6.3%
- Revenue CAGR 5Y
- 7.8%
- EPS Growth YoY
- 56.6%
- Net Income Growth YoY
- 54.6%
Profitability
Trailing 12 months- Gross Margin
- 68.1%
- Operating Margin
- 31.0%
- Net Margin
- 25.4%
- FCF Margin
- 19.3%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $2.22B
- EPS (diluted)
- $7.94
- EBITDA
- $2.94B
- Operating Income
- $2.70B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $674M
- Total Debt
- $15.1B
- Net Debt
- $14.4B
- Total Assets
- $8.68B
- Total Liabilities
- $15.8B
- Shareholders' Equity
- −$7.11B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.08B
- Capital Expenditure
- $404M
- Free Cash Flow
- $1.68B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $2.96
- Beta (5Y)
- 0.55
Every ratio is calculated from the company’s reported figures.